[P1] Poster Discussion 1 (Odd Numbers)

[P-03 (S06-4)] A centringene-deleted Leishmaniavaccine candidate: early and late surrogate markers of immunogenicity

^○Jalal Alshaweesh¹, Ranadhir Dey², Telly Sepahpour², Kamaleshwar Singh³, Patrick Lypaczewski⁴, Subir Karmakar³, Swarnendu Kaviraj³, Sanjay Singh³, Nazli Azodi², Sreenivas Gannavaram², Abhay Satoskar⁵, Greg Matlashewski⁴, Hira Nakhasi², Shinjiro Hamano¹ (1.Institute of Tropical Medicine, Nagasaki University, Japan, 2.Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, USA, 3.Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra, India, 4.Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada, 5.Department of Pathology and Microbiology, Ohio State University, Columbus, OH, USA)